If it was indeed made by GlaxoSmithKline, then this is a good example of "big pharma" greed. Only, in this case, "big pharma" greed might end up saving millions of lives.
That all depends on the price. If the price is reasonable then fine. But typically big pharma that gets a lock-in on 'life' is anything but reasonable in their pricing, after all, what's the value of a human life.
The 5% profits over costs is promising, even if it leaves some wiggle room.
The 5% profits over costs is promising, even if it leaves some wiggle room.